RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY Research Article: Type II DM in MDD Patients with SGA Treatment

Saved in:
Bibliographic Details
Published inDepression and anxiety Vol. 33; no. 5; pp. 435 - 443
Main Authors Lin, Chun-Yuan, Wu, Yu-Hsin, Wang, Hong-Song, Chen, Ping-Kun, Lin, Yuan-Fu, Chien, I-Chia
Format Journal Article
LanguageEnglish
Published 01.05.2016
Online AccessGet full text

Cover

Author Lin, Yuan-Fu
Chien, I-Chia
Wang, Hong-Song
Chen, Ping-Kun
Lin, Chun-Yuan
Wu, Yu-Hsin
Author_xml – sequence: 1
  givenname: Chun-Yuan
  surname: Lin
  fullname: Lin, Chun-Yuan
  organization: School of Medicine; Chung Shan Medical University; Taichung Taiwan, Tsaotun Psychiatric Center; Ministry of Health and Welfare; Nantou Taiwan, National Changhua University of Education; Changhua Taiwan
– sequence: 2
  givenname: Yu-Hsin
  surname: Wu
  fullname: Wu, Yu-Hsin
  organization: National Changhua University of Education; Changhua Taiwan, Feng Yuan Hospital; Ministry of Health and Welfare; Taichung Taiwan
– sequence: 3
  givenname: Hong-Song
  surname: Wang
  fullname: Wang, Hong-Song
  organization: Department of psychiatry; Changhua Hospital; Ministry of Health and Welfare; Chanhua Taiwan
– sequence: 4
  givenname: Ping-Kun
  surname: Chen
  fullname: Chen, Ping-Kun
  organization: Department of Neurology; Lin-Shin Hospital; Taichung Taiwan, School of Medicine; China Medical University; Taichung Taiwan
– sequence: 5
  givenname: Yuan-Fu
  surname: Lin
  fullname: Lin, Yuan-Fu
  organization: College of Management; National Taiwan University; Taipei Taiwan
– sequence: 6
  givenname: I-Chia
  surname: Chien
  fullname: Chien, I-Chia
  organization: Tsaotun Psychiatric Center; Ministry of Health and Welfare; Nantou Taiwan, Department of Public Health and Institute of Public Health; National Yang-Ming University; Taipei Taiwan
BookMark eNqVj7FOwzAURT0UqS0g8QlvZEmxQ4UStsh-bZ5Q7Mh-pcpkRTSVQNCieELi4ykVP8B0h3vOcOZicjgeBiFulFwoKfO7Xb_I82VRTsRMyVJly_yhnIp5Sm9SyqIs5Ex8ewpP4FZgcQvOBmTgrkUgAtMAWWiMgbZiQssBPGqkZ7JrCKidNdkaLfrT6yxUlqkNna4dkw7AHituTtYjVGDPyJYMgna18wyBN6a7Ehf7_j0N1397KW5XyLrOXsZjSuOwj5_j60c_fkUl429R3PXxXHT_D_QH-P1K4g
Cites_doi 10.1001/jama.289.23.3095
10.7326/0003-4819-147-9-200711060-00003
10.1080/01621459.1984.10478078
10.1371/journal.pmed.1001403
10.1097/01.JGP.0000308883.64832.ed
10.1002/da.22387
10.1093/aje/kwi307
10.4088/JCP.v68n0604
10.1176/appi.ajp.2009.09060802
10.1001/jama.2013.4135
10.2165/00023210-200923070-00004
10.1097/PRS.0b013e3181f44abc
10.1111/acps.12301
10.1093/epirev/mxq019
10.4088/JCP.v66n1118
10.1038/sj.npp.1301113
10.1002/da.20740
10.1142/7468
10.2147/NDT.S18333
10.1176/appi.ajp.157.6.975
10.1017/S1092852900020216
10.1176/appi.ajp.2011.11060948
10.1176/appi.ajp.2012.12070927
10.1016/j.jagp.2014.04.003
10.4088/JCP.14m09298
10.1111/cas.12094
10.1016/j.jpsychores.2013.06.003
10.1002/da.20505
10.1001/2012.jama.11975
10.4088/JCP.v69n0108
10.4088/JCP.13m08675
10.4088/JCP.13m08642
10.1176/appi.ajp.2009.09030312
10.2147/NDT.S5819
10.1176/ajp.2006.163.11.1905
10.1002/da.20275
10.1016/j.comppsych.2011.06.004
10.1111/j.1600-0447.2008.01334.x
10.2337/diacare.27.2.421
10.4088/JCP.13m08843
10.1192/bjp.174.4.297
10.1038/npp.2014.101
10.1016/j.eurpsy.2013.12.001
10.1177/0269881115581093
10.1002/da.22378
10.4088/JCP.08m04629
10.4088/JCP.08r04392
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1002/da.22489
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Psychology
EndPage 443
ExternalDocumentID 10_1002_da_22489
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
24P
31~
33P
36B
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJEY
AAONW
AASGY
AAWTL
AAXRX
AAYXX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIJN
ABIVO
ABPVW
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACHQT
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFGKR
AFPWT
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CITATION
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H13
HBH
HF~
HHY
HVGLF
HZ~
IX1
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RHX
ROL
RWI
RX1
RYL
SUPJJ
SV3
TEORI
TUS
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WQJ
WRC
WVDHM
WXI
XG1
XPP
XV2
ZZTAW
~IA
~WT
ID FETCH-crossref_primary_10_1002_da_224893
ISSN 1091-4269
IngestDate Fri Aug 23 01:05:00 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-crossref_primary_10_1002_da_224893
ParticipantIDs crossref_primary_10_1002_da_22489
PublicationCentury 2000
PublicationDate 2016-05-00
PublicationDateYYYYMMDD 2016-05-01
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-00
PublicationDecade 2010
PublicationTitle Depression and anxiety
PublicationYear 2016
References Rapaport (10.1002/da.22489-BIB0012|da22489-cit-0012) 2006; 31
10.1002/da.22489-BIB0023|da22489-cit-0023
American Psychiatric Association (10.1002/da.22489-BIB0032|da22489-cit-0032) 2010
Lin (10.1002/da.22489-BIB0024|da22489-cit-0024) 2013; 104
Simon (10.1002/da.22489-BIB0041|da22489-cit-0041) 2009; 70
Berman (10.1002/da.22489-BIB0013|da22489-cit-0013) 2007; 68
Brunner (10.1002/da.22489-BIB0039|da22489-cit-0039) 2014; 39
Brown (10.1002/da.22489-BIB0004|da22489-cit-0004) 2009; 23
Nelson (10.1002/da.22489-BIB0048|da22489-cit-0048) 2008; 16
Greenberg (10.1002/da.22489-BIB0002|da22489-cit-0002) 2015; 76
Bollini (10.1002/da.22489-BIB0054|da22489-cit-0054) 1999; 174
Cleare (10.1002/da.22489-BIB0010|da22489-cit-0010) 2015; 29
Lin (10.1002/da.22489-BIB0052|da22489-cit-0052) 2005; 104
Chien (10.1002/da.22489-BIB0046|da22489-cit-0046) 2013; 75
Spielmans (10.1002/da.22489-BIB0022|da22489-cit-0022) 2013; 10
Mauskopf (10.1002/da.22489-BIB0003|da22489-cit-0003) 2009; 26
Mahmoud (10.1002/da.22489-BIB0011|da22489-cit-0011) 2007; 147
Zhou (10.1002/da.22489-BIB0029|da22489-cit-0029) 2005; 162
Goldberg (10.1002/da.22489-BIB0020|da22489-cit-0020) 2015; 32
Vancampfort (10.1002/da.22489-BIB0007|da22489-cit-0007) 2015; 32
Citrome (10.1002/da.22489-BIB0027|da22489-cit-0027) 2013; 74
Liebowitz (10.1002/da.22489-BIB0040|da22489-cit-0040) 2010; 27
Henderson (10.1002/da.22489-BIB0034|da22489-cit-0034) 2000; 157
Gardner (10.1002/da.22489-BIB0055|da22489-cit-0055) 2010; 167
Egede (10.1002/da.22489-BIB0005|da22489-cit-0005) 2004; 27
Buijsse (10.1002/da.22489-BIB0047|da22489-cit-0047) 2011; 33
Chien (10.1002/da.22489-BIB0006|da22489-cit-0006) 2012; 53
Berman (10.1002/da.22489-BIB0014|da22489-cit-0014) 2009; 14
Bobo (10.1002/da.22489-BIB0015|da22489-cit-0015) 2009; 5
Komossa (10.1002/da.22489-BIB0018|da22489-cit-0018) 2010; 8
Rosenbaum (10.1002/da.22489-BIB0030|da22489-cit-0030) 1984; 79
Lin (10.1002/da.22489-BIB0051|da22489-cit-0051) 2008; 69
Kessler (10.1002/da.22489-BIB0001|da22489-cit-0001) 2003; 289
Stahl (10.1002/da.22489-BIB0045|da22489-cit-0045) 2009; 119
Kornstein (10.1002/da.22489-BIB0031|da22489-cit-0031) 2001; 62
Wu (10.1002/da.22489-BIB0025|da22489-cit-0025) 2012; 308
Sadock (10.1002/da.22489-BIB0026|da22489-cit-0026) 2003
IsHak (10.1002/da.22489-BIB0042|da22489-cit-0042) 2015; 131
London (10.1002/da.22489-BIB0033|da22489-cit-0033) 2013; 309
Bauer (10.1002/da.22489-BIB0016|da22489-cit-0016) 2009; 70
10.1002/da.22489-BIB0036|da22489-cit-0036
10.1002/da.22489-BIB0053|da22489-cit-0053
Nelson (10.1002/da.22489-BIB0009|da22489-cit-0009) 2009; 166
Papakostas (10.1002/da.22489-BIB0044|da22489-cit-0044) 2010
Rush (10.1002/da.22489-BIB0008|da22489-cit-0008) 2006; 163
Andersen (10.1002/da.22489-BIB0038|da22489-cit-0038) 2005; 66
Nelson (10.1002/da.22489-BIB0049|da22489-cit-0049) 2013; 170
McIntyre (10.1002/da.22489-BIB0017|da22489-cit-0017) 2007; 24
Leon (10.1002/da.22489-BIB0028|da22489-cit-0028) 2012; 169
Song (10.1002/da.22489-BIB0035|da22489-cit-0035) 2010; 126
Huang (10.1002/da.22489-BIB0050|da22489-cit-0050) 2015; 23
Hoertel (10.1002/da.22489-BIB0043|da22489-cit-0043) 2014; 29
Lin (10.1002/da.22489-BIB0019|da22489-cit-0019) 2014; 75
Berman (10.1002/da.22489-BIB0021|da22489-cit-0021) 2011; 7
Gerhard (10.1002/da.22489-BIB0037|da22489-cit-0037) 2014; 75
References_xml – volume: 289
  start-page: 3095
  issue: 23
  year: 2003
  ident: 10.1002/da.22489-BIB0001|da22489-cit-0001
  article-title: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.289.23.3095
  contributor:
    fullname: Kessler
– volume: 147
  start-page: 593
  issue: 9
  year: 2007
  ident: 10.1002/da.22489-BIB0011|da22489-cit-0011
  article-title: Risperidone for treatment-refractory major depressive disorder
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-147-9-200711060-00003
  contributor:
    fullname: Mahmoud
– volume: 79
  start-page: 516
  issue: 387
  year: 1984
  ident: 10.1002/da.22489-BIB0030|da22489-cit-0030
  article-title: Reducing bias in observational studies using subclassification on the propensity score
  publication-title: J Am Stat Assoc
  doi: 10.1080/01621459.1984.10478078
  contributor:
    fullname: Rosenbaum
– volume: 10
  start-page: e1001403
  issue: 3
  year: 2013
  ident: 10.1002/da.22489-BIB0022|da22489-cit-0022
  article-title: Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001403
  contributor:
    fullname: Spielmans
– volume: 16
  start-page: 558
  issue: 7
  year: 2008
  ident: 10.1002/da.22489-BIB0048|da22489-cit-0048
  article-title: Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence
  publication-title: Am J Geriatr Psychiatry
  doi: 10.1097/01.JGP.0000308883.64832.ed
  contributor:
    fullname: Nelson
– volume: 32
  start-page: 763
  issue: 10
  year: 2015
  ident: 10.1002/da.22489-BIB0007|da22489-cit-0007
  article-title: Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors
  publication-title: Depress Anxiety
  doi: 10.1002/da.22387
  contributor:
    fullname: Vancampfort
– volume: 162
  start-page: 1016
  issue: 10
  year: 2005
  ident: 10.1002/da.22489-BIB0029|da22489-cit-0029
  article-title: Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwi307
  contributor:
    fullname: Zhou
– volume: 68
  start-page: 843
  issue: 6
  year: 2007
  ident: 10.1002/da.22489-BIB0013|da22489-cit-0013
  article-title: The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.v68n0604
  contributor:
    fullname: Berman
– volume: 167
  start-page: 686
  issue: 6
  year: 2010
  ident: 10.1002/da.22489-BIB0055|da22489-cit-0055
  article-title: International consensus study of antipsychotic dosing
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2009.09060802
  contributor:
    fullname: Gardner
– volume: 309
  start-page: 1704
  issue: 16
  year: 2013
  ident: 10.1002/da.22489-BIB0033|da22489-cit-0033
  article-title: Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.2013.4135
  contributor:
    fullname: London
– volume: 23
  start-page: 583
  year: 2009
  ident: 10.1002/da.22489-BIB0004|da22489-cit-0004
  article-title: Cardiovascular abnormalities in patients with major depressive disorder
  publication-title: CNS Drugs
  doi: 10.2165/00023210-200923070-00004
  contributor:
    fullname: Brown
– volume: 126
  start-page: 2234
  issue: 6
  year: 2010
  ident: 10.1002/da.22489-BIB0035|da22489-cit-0035
  article-title: Observational studies: cohort and case-control studies
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0b013e3181f44abc
  contributor:
    fullname: Song
– volume: 62
  start-page: 18
  issue: Suppl 16
  year: 2001
  ident: 10.1002/da.22489-BIB0031|da22489-cit-0031
  article-title: Clinical features of treatment-resistant depression
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Kornstein
– volume: 131
  start-page: 51
  issue: 1
  year: 2015
  ident: 10.1002/da.22489-BIB0042|da22489-cit-0042
  article-title: Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12301
  contributor:
    fullname: IsHak
– volume: 33
  start-page: 46
  issue: 1
  year: 2011
  ident: 10.1002/da.22489-BIB0047|da22489-cit-0047
  article-title: Risk assessment tools for identifying individuals at risk of developing type 2 diabetes
  publication-title: Epidemiol Rev
  doi: 10.1093/epirev/mxq019
  contributor:
    fullname: Buijsse
– volume: 66
  start-page: 1468
  issue: 11
  year: 2005
  ident: 10.1002/da.22489-BIB0038|da22489-cit-0038
  article-title: Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.v66n1118
  contributor:
    fullname: Andersen
– volume: 31
  start-page: 2505
  issue: 11
  year: 2006
  ident: 10.1002/da.22489-BIB0012|da22489-cit-0012
  article-title: Effects of risperidone augmentation in patients with treatment-resistant depression: results ofopenlabel treatment followed by double-blind continuation
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301113
  contributor:
    fullname: Rapaport
– volume: 27
  start-page: 964
  issue: 10
  year: 2010
  ident: 10.1002/da.22489-BIB0040|da22489-cit-0040
  article-title: Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
  publication-title: Depress Anxiety
  doi: 10.1002/da.20740
  contributor:
    fullname: Liebowitz
– volume-title: Pharmacotherapy for Depression and Treatment-Resistant Depression
  year: 2010
  ident: 10.1002/da.22489-BIB0044|da22489-cit-0044
  doi: 10.1142/7468
  contributor:
    fullname: Papakostas
– volume: 7
  start-page: 303
  year: 2011
  ident: 10.1002/da.22489-BIB0021|da22489-cit-0021
  article-title: Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
  publication-title: Neuropsychiatr Dis Treat
  doi: 10.2147/NDT.S18333
  contributor:
    fullname: Berman
– volume: 157
  start-page: 975
  issue: 6
  year: 2000
  ident: 10.1002/da.22489-BIB0034|da22489-cit-0034
  article-title: Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.157.6.975
  contributor:
    fullname: Henderson
– volume: 14
  start-page: 197
  issue: 4
  year: 2009
  ident: 10.1002/da.22489-BIB0014|da22489-cit-0014
  article-title: Aripiprazole augmentation in major depressive disorder: A double-blind, placebo-controlled study in patients with inadequate response to antidepressants
  publication-title: CNS Spectr
  doi: 10.1017/S1092852900020216
  contributor:
    fullname: Berman
– volume: 169
  start-page: 285
  issue: 3
  year: 2012
  ident: 10.1002/da.22489-BIB0028|da22489-cit-0028
  article-title: Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11060948
  contributor:
    fullname: Leon
– volume: 170
  start-page: 651
  issue: 6
  year: 2013
  ident: 10.1002/da.22489-BIB0049|da22489-cit-0049
  article-title: Moderators of outcome in late-life depression: a patient-level meta-analysis
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2012.12070927
  contributor:
    fullname: Nelson
– volume: 23
  start-page: 261
  issue: 3
  year: 2015
  ident: 10.1002/da.22489-BIB0050|da22489-cit-0050
  article-title: A systematic review and meta-analysis of psychotherapy for late-life depression
  publication-title: Am J Geriatr Psychiatry
  doi: 10.1016/j.jagp.2014.04.003
  contributor:
    fullname: Huang
– volume: 76
  start-page: 155
  issue: 2
  year: 2015
  ident: 10.1002/da.22489-BIB0002|da22489-cit-0002
  article-title: The economic burden of adults with major depressive disorder in the United States (2005 and 2010)
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.14m09298
  contributor:
    fullname: Greenberg
– volume: 104
  start-page: 383
  issue: 3
  year: 2013
  ident: 10.1002/da.22489-BIB0024|da22489-cit-0024
  article-title: Inverse association between cancer risks and age in schizophrenic patients: a 12-year nationwide cohort study
  publication-title: Cancer Sci
  doi: 10.1111/cas.12094
  contributor:
    fullname: Lin
– volume-title: Practice guideline for the treatment of patients with major depressive disorder
  year: 2010
  ident: 10.1002/da.22489-BIB0032|da22489-cit-0032
  contributor:
    fullname: American Psychiatric Association
– volume: 75
  start-page: 270
  issue: 3
  year: 2013
  ident: 10.1002/da.22489-BIB0046|da22489-cit-0046
  article-title: Increased risk of hyperlipidemia in patients with major depressive disorder: a population-based study
  publication-title: J Psychosom Res
  doi: 10.1016/j.jpsychores.2013.06.003
  contributor:
    fullname: Chien
– volume: 26
  start-page: 83
  year: 2009
  ident: 10.1002/da.22489-BIB0003|da22489-cit-0003
  article-title: Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder
  publication-title: Depress Anxiety
  doi: 10.1002/da.20505
  contributor:
    fullname: Mauskopf
– volume: 308
  start-page: 1906
  issue: 18
  year: 2012
  ident: 10.1002/da.22489-BIB0025|da22489-cit-0025
  article-title: Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection
  publication-title: J Am Med Assoc
  doi: 10.1001/2012.jama.11975
  contributor:
    fullname: Wu
– volume: 69
  start-page: 54
  issue: 1
  year: 2008
  ident: 10.1002/da.22489-BIB0051|da22489-cit-0051
  article-title: Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.v69n0108
  contributor:
    fullname: Lin
– volume: 75
  start-page: 490
  issue: 5
  year: 2014
  ident: 10.1002/da.22489-BIB0037|da22489-cit-0037
  article-title: National trends in second-generation antipsychotic augmentation for nonpsychotic depression
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.13m08675
  contributor:
    fullname: Gerhard
– ident: 10.1002/da.22489-BIB0023|da22489-cit-0023
– volume: 74
  start-page: 1199
  issue: 12
  year: 2013
  ident: 10.1002/da.22489-BIB0027|da22489-cit-0027
  article-title: Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.13m08642
  contributor:
    fullname: Citrome
– volume: 166
  start-page: 980
  issue: 9
  year: 2009
  ident: 10.1002/da.22489-BIB0009|da22489-cit-0009
  article-title: Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2009.09030312
  contributor:
    fullname: Nelson
– volume: 5
  start-page: 369
  issue: 1
  year: 2009
  ident: 10.1002/da.22489-BIB0015|da22489-cit-0015
  article-title: Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
  publication-title: Neuropsychiatr Dis Treat
  doi: 10.2147/NDT.S5819
  contributor:
    fullname: Bobo
– volume: 163
  start-page: 1905
  issue: 11
  year: 2006
  ident: 10.1002/da.22489-BIB0008|da22489-cit-0008
  article-title: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.2006.163.11.1905
  contributor:
    fullname: Rush
– volume: 24
  start-page: 487
  issue: 7
  year: 2007
  ident: 10.1002/da.22489-BIB0017|da22489-cit-0017
  article-title: Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study
  publication-title: Depress Anxiety
  doi: 10.1002/da.20275
  contributor:
    fullname: McIntyre
– volume: 53
  start-page: 569
  issue: 5
  year: 2012
  ident: 10.1002/da.22489-BIB0006|da22489-cit-0006
  article-title: Prevalence of diabetes in patients with major depressive disorder: a population-based study
  publication-title: Compr Psychiatry
  doi: 10.1016/j.comppsych.2011.06.004
  contributor:
    fullname: Chien
– volume: 119
  start-page: 171
  issue: 3
  year: 2009
  ident: 10.1002/da.22489-BIB0045|da22489-cit-0045
  article-title: Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/j.1600-0447.2008.01334.x
  contributor:
    fullname: Stahl
– volume: 27
  start-page: 421
  issue: 2
  year: 2004
  ident: 10.1002/da.22489-BIB0005|da22489-cit-0005
  article-title: Diabetes, major depression, and functional disability among U.S. adults
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.2.421
  contributor:
    fullname: Egede
– volume: 8
  start-page: CD008121
  issue: 23
  year: 2010
  ident: 10.1002/da.22489-BIB0018|da22489-cit-0018
  article-title: Second-generation antipsychotics for major depressive disorder and dysthymia
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: Komossa
– volume-title: Kaplan & Sadock's Synopsis of Psychiatry
  year: 2003
  ident: 10.1002/da.22489-BIB0026|da22489-cit-0026
  contributor:
    fullname: Sadock
– volume: 75
  start-page: e924
  issue: 9
  year: 2014
  ident: 10.1002/da.22489-BIB0019|da22489-cit-0019
  article-title: Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.13m08843
  contributor:
    fullname: Lin
– volume: 104
  start-page: 157
  issue: 3
  year: 2005
  ident: 10.1002/da.22489-BIB0052|da22489-cit-0052
  article-title: Accuracy of diabetes diagnosis in health insurance claims data in Taiwan
  publication-title: J Formos Med Assoc
  contributor:
    fullname: Lin
– volume: 174
  start-page: 297
  issue: 4
  year: 1999
  ident: 10.1002/da.22489-BIB0054|da22489-cit-0054
  article-title: Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.174.4.297
  contributor:
    fullname: Bollini
– volume: 39
  start-page: 2549
  issue: 11
  year: 2014
  ident: 10.1002/da.22489-BIB0039|da22489-cit-0039
  article-title: Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.101
  contributor:
    fullname: Brunner
– volume: 29
  start-page: 358
  issue: 6
  year: 2014
  ident: 10.1002/da.22489-BIB0043|da22489-cit-0043
  article-title: Poor longitudinal continuity of care is associated with an increased mortality rate among patients with mental disorders: results from the French National Health Insurance Reimbursement Database
  publication-title: Eur Psychiatry
  doi: 10.1016/j.eurpsy.2013.12.001
  contributor:
    fullname: Hoertel
– volume: 29
  start-page: 459
  issue: 5
  year: 2015
  ident: 10.1002/da.22489-BIB0010|da22489-cit-0010
  article-title: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881115581093
  contributor:
    fullname: Cleare
– volume: 32
  start-page: 605
  issue: 8
  year: 2015
  ident: 10.1002/da.22489-BIB0020|da22489-cit-0020
  article-title: The American Society of Clinical Psychopharmacology Survey of Psychopharmacologists' Practice Patterns for the Treatment of Mood Disorders
  publication-title: Depress Anxiety
  doi: 10.1002/da.22378
  contributor:
    fullname: Goldberg
– volume: 70
  start-page: 540
  issue: 4
  year: 2009
  ident: 10.1002/da.22489-BIB0016|da22489-cit-0016
  article-title: Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.08m04629
  contributor:
    fullname: Bauer
– volume: 70
  start-page: 1041
  issue: 7
  year: 2009
  ident: 10.1002/da.22489-BIB0041|da22489-cit-0041
  article-title: Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.08r04392
  contributor:
    fullname: Simon
– ident: 10.1002/da.22489-BIB0036|da22489-cit-0036
– ident: 10.1002/da.22489-BIB0053|da22489-cit-0053
SSID ssj0008980
Score 4.378653
SourceID crossref
SourceType Aggregation Database
StartPage 435
Subtitle Research Article: Type II DM in MDD Patients with SGA Treatment
Title RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja9tAFB7c9JJL6Up3XqGHwjBpYi22ehPWBE2DZSNN6-RkrEguucghtaAtvfdv982ixUmhaS9CDNrQ-3jv0-h73xDy9shBGBXrMSuL9Zq5WDJYjlWPIVMO3NIb-kWhGpyniR9_cj-eeqeDwa-eaqne5gfnP_7YV_I_UcUxjKvqkv2HyLYXxQHcx_jiFiOM21vFOBXZiZLtJHxBZ0nGJZVnc06FoNGUioROo4jOQyl4IjOa8gkXn9XkVKZWL4yYUa3pVXfCRArzW0mKSUZlykOpXP5N37pxzF2IiNPJLJ6lUvPIHV4bNYLayrq_fmsMRrTa58L-2q8rdlZ3eFzUugLULP560Q3aGex4U31h2cZWVq1AMClyjtWWndRVf8LiyO_kgTbHIkVhqoO2n4SNG4YFm9fLqK5xM7HF2TWeTjfyvvGRLVYHyEjMkkS71trXSl4rRDSmzcNlsVrqM--Qu8NR4CltaJR2PmTjYGxsLeyTNy7Gh8P3zT17vKZHUOR9cs9-WUBoYPKADMrqIdlvC9z3R-SnwgvMjgHxAhovoPACQkA0BZEA4gUavECLF7iBF9jFC7R4-QAhdGgBgxbQaHlM3h1zOYlZ8_zLS2N0srz-dpwnZK_aVOVTAkHh-ytk787IXSGnL4LcCdxg5JSHee6X594z8uavl3t-i2NekP0OQy_J3vaqLl8hDdzmr3WIfgOcO07O
link.rule.ids 315,786,790,27955,27956
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=RISK+OF+NEW+ONSET+TYPE+II+DM+IN+MDD+PATIENTS+RECEIVING+SECOND-GENERATION+ANTIPSYCHOTICS+TREATMENT%3A+A+NATIONWIDE+COHORT+STUDY&rft.jtitle=Depression+and+anxiety&rft.au=Lin%2C+Chun-Yuan&rft.au=Wu%2C+Yu-Hsin&rft.au=Wang%2C+Hong-Song&rft.au=Chen%2C+Ping-Kun&rft.date=2016-05-01&rft.issn=1091-4269&rft.volume=33&rft.issue=5&rft.spage=435&rft.epage=443&rft_id=info:doi/10.1002%2Fda.22489&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_da_22489
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1091-4269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1091-4269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1091-4269&client=summon